The EMA, based on the opinion of the Committee for Medicinal Products for Veterinary Use, has recommended that the establishment of an MRL for bambermycin in rabbits is not necessary for the protection of human health.
Recital 5, Regulation (EU) 2020/42
In forcesince 17 Jan 2020